Prolactin-induced protein

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Prolactin-induced protein
Protein PIP PDB 2icn.png
PDB rendering based on 2icn.
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
Symbols PIP ; GCDFP-15; GCDFP15; GPIP4
External IDs OMIM176720 MGI102696 HomoloGene1990 GeneCards: PIP Gene
RNA expression pattern
PBB GE PIP 206509 at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 5304 18716
Ensembl ENSG00000159763 ENSMUSG00000058499
UniProt P12273 P02816
RefSeq (mRNA) NM_002652 NM_008843
RefSeq (protein) NP_002643 NP_032869
Location (UCSC) Chr 7:
142.83 – 142.84 Mb
Chr 6:
41.85 – 41.85 Mb
PubMed search [1] [2]

Prolactin-inducible protein also known as gross cystic disease fluid protein 15 (GCDFP-15), extra-parotid glycoprotein (EP-GP), gp17 seminal actin-binding protein (SABP) or BRST2 is a protein that in humans is encoded by the PIP gene.[1][2][3] It is upregulated by prolactin and androgens and downregulated by estrogen.

Function[edit]

The protein has a physiological function in regulation of water transport mainly in apocrine glands in the axilla, vulva, eyelid and ear canal, serous cells of the submandibular salivary gland, serous cells of the submucosal glands of the bronchi, and accessory lacrimal glands as well as cutaneous eccrine glands.[4] It is also found in amniotic fluid and seminal fluid.

PIP has the ability to bind immunoglobulin G (IgG), IgG-Fc, CD4-T cell receptor suggesting a wide range of immunological functions.[5][6] PIP also binds to AZGP1.[6] PIP exerts aspartyl proteinase activity able to cleave fibronectin.[7][8]

PIP can bind different species of bacteria showing highest affinity to sterptococci thus playing a role in non-immune defense of the body against pathogenic bacterial strains.[9][10]

Mitogenic effect of PIP was observed on both normal and malignant breast epithelial cells.[11]

Use as marker and significance in disease[edit]

Prolactin induced protein (called GCDFP-15 in this context) in breast cyst fluid or breast tissue serves as marker of both benign and malignant apocrine metaplasia as the protein is not normally expressed in breast tissue.[12][13] It is characteristic of low grade apocrine carcinoma of the breast, high grade apocrine carcinoma frequently loose expression of this marker.[14] PIP gene expression in breast cancer lines was associated with decreased cell proliferation and invasivenes and an increase of the apoptotic pathway. Many of the genes affected by PIP appear to be regulated by STAT5.[15]

A mitogenic effect of this protein on experimental breast cells lines MCF10A, MCF7, BT474, MDA-MB231 and T47D was detected.[11] Prolactin-induced protein has also been used for identification and detection of disseminated breast cancer cells.[16]

The PIP gene is amplified in some breast cancer lines accounting for some of its overexpression, however additional mechanisms are needed to completely explain its overexpression.[17] In T47D breast cancer cells, androgen receptor and RUNX2 interact to synergistically enhance PIP expression.[18]

In molecular apocrine breast cancer (ER-/AR+) there is a positive feedback loop between androgen receptor and extracellular signal-regulated kinase (ERK) via CREB1 which can be inhibited by anti-androgens. PIP expression is necessary for viability and invasiveness of this subtype of breast cancer.[19]

In ER+ breast cancer, particularly those with very high level of ER expression, PIP appears to play an important role in proliferation and invasion as well as acquired resistance to tamoxifen.[20]

It has been hypothesized that in Sjögren's syndrome PIP binds to the C-terminal portion of aquaporin-5 and causes it to be transported to the apical membrane causing disruptions of water transport.[21][22]

References[edit]

  1. ^ Myal Y, Gregory C, Wang H, Hamerton JL, Shiu RP (July 1989). "The gene for prolactin-inducible protein (PIP), uniquely expressed in exocrine organs, maps to chromosome 7". Somat Cell Mol Genet 15 (3): 265–70. doi:10.1007/BF01534877. PMID 2727805. 
  2. ^ Myal Y, Robinson DB, Iwasiow B, Tsuyuki D, Wong P, Shiu RP (January 1992). "The prolactin-inducible protein (PIP/GCDFP-15) gene: cloning, structure and regulation". Mol Cell Endocrinol 80 (1–3): 165–75. doi:10.1016/0303-7207(91)90153-J. PMID 1955075. 
  3. ^ "Entrez Gene: PIP prolactin-induced protein". 
  4. ^ Mazoujian G, Pinkus GS, Davis S, Haagensen DE (February 1983). "Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features". Am. J. Pathol. 110 (2): 105–12. PMC 1916150. PMID 6130702. 
  5. ^ Chiu WW, Chamley LW (December 2003). "Human seminal plasma prolactin-inducible protein is an immunoglobulin G-binding protein". J. Reprod. Immunol. 60 (2): 97–111. doi:10.1016/S0165-0378(03)00084-6. PMID 14638438. 
  6. ^ a b Hassan MI, Waheed A, Yadav S, Singh TP, Ahmad F (February 2009). "Prolactin inducible protein in cancer, fertility and immunoregulation: structure, function and its clinical implications". Cell. Mol. Life Sci. 66 (3): 447–59. doi:10.1007/s00018-008-8463-x. PMID 18854942. 
  7. ^ Caputo E, Camarca A, Moharram R, Tornatore P, Thatcher B, Guardiola J, Martin BM (May 2003). "Structural study of GCDFP-15/gp17 in disease versus physiological conditions using a proteomic approach". Biochemistry 42 (20): 6169–78. doi:10.1021/bi034038a. PMID 12755619. 
  8. ^ Caputo E, Manco G, Mandrich L, Guardiola J (March 2000). "A novel aspartyl proteinase from apocrine epithelia and breast tumors". J. Biol. Chem. 275 (11): 7935–41. doi:10.1074/jbc.275.11.7935. PMID 10713110. 
  9. ^ Lee B, Bowden GH, Myal Y (April 2002). "Identification of mouse submaxillary gland protein in mouse saliva and its binding to mouse oral bacteria". Arch. Oral Biol. 47 (4): 327–32. doi:10.1016/S0003-9969(01)00113-3. PMID 11922875. 
  10. ^ Schenkels LC, Walgreen-Weterings E, Oomen LC, Bolscher JG, Veerman EC, Nieuw Amerongen AV (February 1997). "In vivo binding of the salivary glycoprotein EP-GP (identical to GCDFP-15) to oral and non-oral bacteria detection and identification of EP-GP binding species". Biol. Chem. 378 (2): 83–8. doi:10.1515/bchm.1997.378.2.83. PMID 9088536. 
  11. ^ a b Cassoni P, Sapino A, Haagensen DE, Naldoni C, Bussolati G (January 1995). "Mitogenic effect of the 15-kDa gross cystic disease fluid protein (GCDFP-15) on breast-cancer cell lines and on immortal mammary cells". Int. J. Cancer 60 (2): 216–20. doi:10.1002/ijc.2910600215. PMID 7829219. 
  12. ^ Collette J, Hendrick JC, Jaspar JM, Franchimont P (July 1986). "Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid". Cancer Res. 46 (7): 3728–33. PMID 3486713. 
  13. ^ Petrakis NL, Lowenstein JM, Wiencke JK, Lee MM, Wrensch MR, King EB, Hilton JF, Miike R (1993). "Gross cystic disease fluid protein in nipple aspirates of breast fluid of Asian and non-Asian women". Cancer Epidemiol. Biomarkers Prev. 2 (6): 573–9. PMID 8268776. 
  14. ^ Honma N, Takubo K, Arai T, Younes M, Kasumi F, Akiyama F, Sakamoto G (2006). "Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast". APMIS 114 (10): 712–9. doi:10.1111/j.1600-0463.2006.apm_434.x. PMID 17004974. 
  15. ^ Debily MA, Marhomy SE, Boulanger V, Eveno E, Mariage-Samson R, Camarca A, Auffray C, Piatier-Tonneau D, Imbeaud S (2009). "A functional and regulatory network associated with PIP expression in human breast cancer". PLoS ONE 4 (3): e4696. doi:10.1371/journal.pone.0004696. PMC 2650800. PMID 19262752. 
  16. ^ Lacroix M (December 2006). "Significance, detection and markers of disseminated breast cancer cells". Endocr. Relat. Cancer 13 (4): 1033–67. doi:10.1677/ERC-06-0001. PMID 17158753. 
  17. ^ Ciullo M, Debily MA, Rozier L, Autiero M, Billault A, Mayau V, El Marhomy S, Guardiola J, Bernheim A, Coullin P, Piatier-Tonneau D, Debatisse M (November 2002). "Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I". Hum. Mol. Genet. 11 (23): 2887–94. doi:10.1093/hmg/11.23.2887. PMID 12393800. 
  18. ^ Baniwal SK, Little GH, Chimge NO, Frenkel B (May 2012). "Runx2 controls a feed-forward loop between androgen and prolactin-induced protein (PIP) in stimulating T47D cell proliferation". J. Cell. Physiol. 227 (5): 2276–82. doi:10.1002/jcp.22966. PMID 21809344. 
  19. ^ Naderi A, Meyer M (2012). "Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer". Breast Cancer Res. 14 (4): R111. doi:10.1186/bcr3232. PMC 3680918. PMID 22817771. 
  20. ^ Baniwal SK, Chimge NO, Jordan VC, Tripathy D, Frenkel B (2013). "Prolactin-induced protein (PIP) regulates proliferation of luminal A type breast cancer cells in an estrogen-independent manner". PLoS ONE 8 (6): e62361. doi:10.1371/journal.pone.0062361. PMC 3670933. PMID 23755096. 
  21. ^ Ohashi Y, Tsuzaka K, Takeuchi T, Sasaki Y, Tsubota K (August 2008). "Altered distribution of aquaporin 5 and its C-terminal binding protein in the lacrimal glands of a mouse model for Sjögren's syndrome". Curr. Eye Res. 33 (8): 621–9. doi:10.1080/02713680802262819. PMID 18696337. 
  22. ^ Gallo A, Martini D, Sernissi F, et al. (June 2013). "Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP) as Functional Salivary Biomarker for Primary Sjögren's Syndrome". J Genet Syndr Gene Ther 4. doi:10.4172/2157-7412.1000140. PMC 3884953. PMID 24416635. 

Further reading[edit]

External links[edit]